相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)
Rodney P. Rocconi et al.
GYNECOLOGIC ONCOLOGY (2007)
Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses
Alan E. Bilsland et al.
CANCER RESEARCH (2007)
A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease
Sophie Dessureault et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells
Gerd J. Bauerschmitz et al.
MOLECULAR THERAPY (2006)
A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer
Eric J. Small et al.
MOLECULAR THERAPY (2006)
Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter
J. J. Davis et al.
CANCER GENE THERAPY (2006)
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation
BY Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor
X Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh et al.
CLINICAL CANCER RESEARCH (2006)
Differential cis-regulation of human versus mouse TERT gene expression in vivo: Identification of a human-specific repressive element
L Horikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models
YH Li et al.
CLINICAL CANCER RESEARCH (2005)
Development of transcriptionally regulated oncolytic adenoviruses
D Ko et al.
ONCOGENE (2005)
An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells
S Bortolanza et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity
J Dilley et al.
CANCER GENE THERAPY (2005)
Telomerase-dependent gene therapy
T Wirth et al.
CURRENT MOLECULAR MEDICINE (2005)
Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice
T Groot-Wassink et al.
CANCER RESEARCH (2004)
Telomerase-specific replication-selective virotherapy for human cancer
T Kawashima et al.
CLINICAL CANCER RESEARCH (2004)
Ad-mTERT-Δ19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner
E Kim et al.
HUMAN GENE THERAPY (2003)
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy
G Halldén et al.
MOLECULAR THERAPY (2003)
Telomerase maintains telomere structure in normal human cells
K Masutomi et al.
CELL (2003)
In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF
JA Bristol et al.
MOLECULAR THERAPY (2003)
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase
AE Bilsland et al.
ONCOGENE (2003)
Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node
C Scheinecker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication
R Hernandez-Alcoceba et al.
HUMAN GENE THERAPY (2002)
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus
D Malone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Telomerase activation, cellular immortalization and cancer
WC Hahn et al.
ANNALS OF MEDICINE (2001)
分享论文
